Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.250 $0.685 Friday, 10th May 2024 ADXS stock ended at $0.437. This is 21.96% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 108.00% from a day low at $0.250 to a day high of $0.520.
90 days $0.250 $1.05
52 weeks $0.250 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Jul 07, 2016 $128.55 $128.55 $128.55 $128.55 39 673
Jul 06, 2016 $130.20 $130.20 $130.20 $130.20 105 253
Jul 05, 2016 $121.20 $121.20 $121.20 $121.20 20 833
Jul 01, 2016 $122.55 $122.55 $122.55 $122.55 36 460
Jun 30, 2016 $121.35 $121.35 $121.35 $121.35 43 413
Jun 29, 2016 $123.45 $123.45 $123.45 $123.45 39 593
Jun 28, 2016 $126.30 $126.30 $126.30 $126.30 76 413
Jun 27, 2016 $109.50 $109.50 $109.50 $109.50 55 847
Jun 24, 2016 $118.65 $118.65 $118.65 $118.65 64 520
Jun 23, 2016 $122.55 $122.55 $122.55 $122.55 41 547
Jun 22, 2016 $121.35 $121.35 $121.35 $121.35 38 160
Jun 21, 2016 $125.70 $125.70 $125.70 $125.70 34 707
Jun 20, 2016 $127.65 $127.65 $127.65 $127.65 44 087
Jun 17, 2016 $120.45 $120.45 $120.45 $120.45 49 020
Jun 16, 2016 $125.70 $125.70 $125.70 $125.70 36 727
Jun 15, 2016 $123.00 $123.00 $123.00 $123.00 37 866
Jun 14, 2016 $120.00 $120.00 $120.00 $120.00 48 272
Jun 13, 2016 $121.35 $121.35 $121.35 $121.35 42 400
Jun 10, 2016 $128.40 $128.40 $128.40 $128.40 52 669
Jun 09, 2016 $132.30 $132.30 $132.30 $132.30 52 722
Jun 08, 2016 $135.15 $135.15 $135.15 $135.15 52 642
Jun 07, 2016 $138.90 $138.90 $138.90 $138.90 51 884
Jun 06, 2016 $144.00 $144.00 $144.00 $144.00 193 066
Jun 03, 2016 $134.55 $134.55 $134.55 $134.55 57 636
Jun 02, 2016 $144.90 $144.90 $144.90 $144.90 64 303
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT